75
|
257
|
3t82A |
Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates |
75
|
257
|
3t84A |
Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates |
78
|
259
|
3sbhA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide |
71
|
257
|
3s73B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
78
|
257
|
3s74B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
79
|
258
|
3saxA |
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-{[(5-ethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide |
73
|
258
|
3s71B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
73
|
257
|
3s75B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
77
|
258
|
3sbiA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-[(2-pyrimidinylsulfanyl)acetyl]benzenesulfonamide |
77
|
266
|
3s97A |
Ptprz cntn1 complex |
76
|
257
|
3s76A |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
76
|
257
|
3s72B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
75
|
258
|
3s78B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
75
|
257
|
3sapA |
Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(5-butyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide |
75
|
258
|
3s77B |
The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase |
74
|
257
|
3ryvB |
Carbonic anhydrase complexed with n-ethyl-4-sulfamoylbenzamide |
73
|
258
|
3ryzA |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
74
|
257
|
3ryyA |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
77
|
257
|
3rz8A |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
71
|
258
|
3rz0B |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
74
|
258
|
3ryxB |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
77
|
258
|
3rz5A |
Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase |
74
|
257
|
3ryjB |
Carbonic anhydrase complexed with 4-sulfamoyl-n-(2,2,2-trifluoroethyl)benzamide |
75
|
257
|
3rldA |
Crystal structure of the y7i mutant of human carbonic anhydrase ii |
75
|
256
|
3rgeA |
Crystal structure of the w5h mutant of human carbonic anhydrase ii |
71
|
255
|
3rg3A |
Crystal structure of the w5e mutant of human carbonic anhydrase ii |
68
|
257
|
3rg4A |
Crystal structure of the w5f mutant of human carbonic anhydrase ii |
78
|
258
|
3rj7A |
Human carbonic anhydrase ii complexed with its inhibitor rhenium(i)triscarbonyl-cyclopentadienyl-carboxy-4-aminomethylbenzene-sulfonamide |
76
|
257
|
3dcwA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
79
|
257
|
3m1qA |
Carbonic anhydrase ii mutant w5c-h64c with opened disulfide bond |
79
|
257
|
3dbuA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
78
|
259
|
3igpA |
Structure of inhibitor binding to carbonic anhydrase ii |
81
|
257
|
5sz7A |
Carbonic anhydrase ix-mimic in complex with 4-(3-quinolinyl)-benzenesulfonamide |
76
|
257
|
5sz6A |
Carbonic anhydrase ix-mimic in complex with 4-(3-formylphenyl)-benzenesulfonamide |
78
|
257
|
5sz1A |
Carbonic anhydrase ii in complex with 4-(2-methylphenyl)-benzenesulfonamide |
78
|
257
|
5sz0A |
Carbonic anhydrase ii in complex with 4-(phenyl)-benzenesulfonamide |
79
|
257
|
5sz3A |
Carbonic anhydrase ii in complex with 4-(3-quinolinyl)-benzenesulfonamide |
77
|
257
|
5sz2A |
Carbonic anhydrase ii in complex with 4-(3-formylphenyl)-benzenesulfonamide |
75
|
257
|
5lmdA |
The crystal structure of hca ii in complex with a benzoxaborole inhibitor |
76
|
258
|
4yxuA |
Human carbonic anhydrase ii complexed with an inhibitor with a benzenesulfonamide group (4). |
73
|
258
|
5jdvB |
Human carbonic anhydrase ii (f131w) complexed with benzo[d]thiazole-2-sulfonamide |
78
|
258
|
5brvA |
Catalytic improvement of an artificial metalloenzyme by computational design |
72
|
259
|
5l3oA |
Crystal structure of human carbonic anhydrase ii in complex with a quinoline oligoamide foldamer |
76
|
261
|
5j8zA |
Human carbonic anhydrase ii in complex with ligand |
76
|
258
|
5jepB |
Human carbonic anhydrase ii (t199s) complexed with benzo[d]thiazole-2-sulfonamide |
75
|
258
|
4z1jA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
80
|
257
|
4zx1A |
Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor |
80
|
257
|
4zx0A |
Human carbonic anhydrase ii in complex with a glucosyl sulfamate inhibitor |
79
|
257
|
5g0bA |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
74
|
259
|
4z1eA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |